Mp16-17 phase i study of intravesical fc-optimized anti-cd40 agonist antibody 2141-v11 for non-muscle invasive bladder cancer (nmibc) unresponsive to bacillus calmette-guerin (bcg)

Journal of Urology(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要